Abstract QS37: Induction Of Delayed Immune Tolerance After Reconstructive Transplantation By Combining Donor Bone Marrow Transplantation And High-dose Cyclophosphamide Treatment

• YINAN GUO,
• Franka Messner, MD,
• Byoung Chol Oh, DVM, PhD,
• Georg J. Furtmüller, MD,
• W.P. Andrew Lee, MD,
• Damon S. Cooney, MD, PhD,
• Leo Luznik, MD,
• Gerald Brandacher, MD

Affiliations

YINAN GUO

1 Department of Plastic and Reconstructive Surgery, Vascularized Composite Allotransplantation Laboratory, Johns Hopkins University School of Medicine, Baltimore, MD, USA

Franka Messner, MD

1 Department of Plastic and Reconstructive Surgery, Vascularized Composite Allotransplantation Laboratory, Johns Hopkins University School of Medicine, Baltimore, MD, USA

Byoung Chol Oh, DVM, PhD

1 Department of Plastic and Reconstructive Surgery, Vascularized Composite Allotransplantation Laboratory, Johns Hopkins University School of Medicine, Baltimore, MD, USA

Georg J. Furtmüller, MD

1 Department of Plastic and Reconstructive Surgery, Vascularized Composite Allotransplantation Laboratory, Johns Hopkins University School of Medicine, Baltimore, MD, USA

W.P. Andrew Lee, MD

1 Department of Plastic and Reconstructive Surgery, Vascularized Composite Allotransplantation Laboratory, Johns Hopkins University School of Medicine, Baltimore, MD, USA

Damon S. Cooney, MD, PhD

1 Department of Plastic and Reconstructive Surgery, Vascularized Composite Allotransplantation Laboratory, Johns Hopkins University School of Medicine, Baltimore, MD, USA

Leo Luznik, MD

2 Division of Hematologic Malignancies, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA

Gerald Brandacher, MD

1 Department of Plastic and Reconstructive Surgery, Vascularized Composite Allotransplantation Laboratory, Johns Hopkins University School of Medicine, Baltimore, MD, USA